Cell Line : ECC12
Cellosaurus Index : CVCL_1189
Cellosaurus ID : ECC12
CTRP2 Name
, GDSC1 Name
, GDSC2 Name
: ECC12
CCLE Name
: ECC12_STOMACH
Cancer Type : stomach
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| ECC12 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | 5-Fluorouracil | GDSC2 | 0.0200 | 20.0000 |
|
| ECC12 | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Afatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AGI-6780 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | AKT inhibitor VIII | GDSC1 | 0.0100 | 2.5600 |
|
| ECC12 | Alisertib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | Alpelisib | GDSC2 | 0.0050 | 10.0000 |
|
| ECC12 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| ECC12 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| ECC12 | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Avagacestat | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Axitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| ECC12 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| ECC12 | AZD1208 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD1332 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD2014 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | AZD4547 | GDSC2,CTRP2 | 0.0041 | 66.0000 |
|
| ECC12 | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD5438 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD5582 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD6482 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | AZD6738 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | AZD7762 | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| ECC12 | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | AZD8186 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Bax channel blocker | CTRP2 | 0.0160 | 33.0000 |
|
| ECC12 | BEC | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BI-2536 | GDSC2,CTRP2 | 0.0005 | 33.0000 |
|
| ECC12 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | Bicalutamide | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BIX-01294 | CTRP2 | 0.0160 | 33.0000 |
|
| ECC12 | blebbistatin | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BMS-345541 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BMS-536924 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | BMS-754807 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Bortezomib | GDSC1,GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| ECC12 | Bosutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| ECC12 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K16130065 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| ECC12 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K29086754 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| ECC12 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K58730230 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K71781559 | CTRP2 | 0.0041 | 66.0000 |
|
| ECC12 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| ECC12 | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| ECC12 | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| ECC12 | BRD4770 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | BX795 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| ECC12 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| ECC12 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | CCT-018159 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | CCT007093 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| ECC12 | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| ECC12 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | CHEMBL374350 | CTRP2 | 0.0010 | 17.0000 |
|
| ECC12 | CHIR-99021 | GDSC1,GDSC2,CTRP2 | 0.0024 | 80.0000 |
|
| ECC12 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| ECC12 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| ECC12 | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| ECC12 | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| ECC12 | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| ECC12 | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| ECC12 | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Crizotinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| ECC12 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| ECC12 | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| ECC12 | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Dabrafenib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| ECC12 | Dactolisib | GDSC2 | 0.0003 | 0.2500 |
|
| ECC12 | Daporinad | GDSC2,CTRP2 | 0.0000 | 1.0000 |
|
| ECC12 | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Dasatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| ECC12 | Docetaxel | GDSC2 | 0.0000 | 0.0125 |
|
| ECC12 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | Doramapimod | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| ECC12 | EHT-1864 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| ECC12 | Elesclomol | GDSC2 | 0.0002 | 0.2000 |
|
| ECC12 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Entinostat | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| ECC12 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Erlotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| ECC12 | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| ECC12 | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Foretinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| ECC12 | Fulvestrant | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| ECC12 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Gefitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Gemcitabine | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| ECC12 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | gossypol | CTRP2 | 0.0023 | 37.0000 |
|
| ECC12 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | GSK1904529A | GDSC2 | 0.0050 | 10.0000 |
|
| ECC12 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| ECC12 | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| ECC12 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | GW441756 | GDSC2 | 0.0020 | 2.0000 |
|
| ECC12 | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| ECC12 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | I-BET-762 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | IAP_5620 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| ECC12 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | IOX2 | GDSC2 | 0.0005 | 0.5000 |
|
| ECC12 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | isoliquiritigenin | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| ECC12 | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| ECC12 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | JNK Inhibitor VIII | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| ECC12 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| ECC12 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| ECC12 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | KU-55933 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | L-685458 | CTRP2 | 0.0023 | 37.0000 |
|
| ECC12 | Lapatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| ECC12 | Lenalidomide | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Lestaurtinib | GDSC2 | 0.0020 | 2.0000 |
|
| ECC12 | LGK974 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Linsitinib | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| ECC12 | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| ECC12 | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Methotrexate | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| ECC12 | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| ECC12 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| ECC12 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| ECC12 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | MK-0752 | CTRP2 | 0.0020 | 33.0000 |
|
| ECC12 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | MK-2206 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| ECC12 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| ECC12 | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| ECC12 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Motesanib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| ECC12 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Navitoclax | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0020 | 33.0000 |
|
| ECC12 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ECC12 | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| ECC12 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | neopeltolide | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Nilotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| ECC12 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| ECC12 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| ECC12 | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| ECC12 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | NSC632839 | CTRP2 | 0.0160 | 33.0000 |
|
| ECC12 | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | NU7441 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Nutlin-3a | GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| ECC12 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Obatoclax Mesylate | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Olaparib | GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| ECC12 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | OSI-027 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | Oxaliplatin | GDSC2,CTRP2 | 0.0100 | 66.0000 |
|
| ECC12 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Paclitaxel | GDSC2,CTRP2 | 0.0001 | 66.0000 |
|
| ECC12 | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| ECC12 | Palbociclib | GDSC2 | 0.0040 | 4.0000 |
|
| ECC12 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Parthenolide | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | PD0325901 | GDSC2 | 0.0003 | 2.5000 |
|
| ECC12 | PD173074 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| ECC12 | Pevonedistat | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | PF-4708671 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| ECC12 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | PFI-1 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| ECC12 | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Pictilisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| ECC12 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Piperlongumine | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | PLX-4720 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| ECC12 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| ECC12 | PRIMA-1MET | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| ECC12 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| ECC12 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| ECC12 | QS11 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Rapamycin | GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| ECC12 | Refametinib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Regorafenib | CTRP2 | 0.0320 | 66.0000 |
|
| ECC12 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| ECC12 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | RO-3306 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Rucaparib | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | Ruxolitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| ECC12 | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| ECC12 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | SB216763 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | SB505124 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | SB590885 | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| ECC12 | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| ECC12 | Selumetinib | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ECC12 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ECC12 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ECC12 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ECC12 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ECC12 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ECC12 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ECC12 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ECC12 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0120 | 200.0000 |
|
| ECC12 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| ECC12 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ECC12 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Sepantronium bromide | GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| ECC12 | Serdemetan | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | SGC0946 | GDSC2 | 0.0005 | 0.5000 |
|
| ECC12 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| ECC12 | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| ECC12 | sildenafil | CTRP2 | 0.0160 | 270.0000 |
|
| ECC12 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| ECC12 | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | SL0101 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | SN-38 | GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| ECC12 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0020 | 17.0000 |
|
| ECC12 | Sorafenib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Staurosporine | GDSC2,CTRP2 | 0.0001 | 3.3000 |
|
| ECC12 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| ECC12 | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| ECC12 | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Talazoparib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Tamoxifen | GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| ECC12 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Tanespimycin | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| ECC12 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| ECC12 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Temozolomide | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Temsirolimus | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| ECC12 | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | TGX221 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| ECC12 | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Trametinib | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | Tretinoin | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| ECC12 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| ECC12 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| ECC12 | Tubastatin A | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| ECC12 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| ECC12 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| ECC12 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Veliparib | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| ECC12 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| ECC12 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| ECC12 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| ECC12 | Vismodegib | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Vorinostat | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0320 | 66.0000 |
|
| ECC12 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| ECC12 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | Wee1 Inhibitor | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | XAV939 | GDSC2 | 0.0050 | 10.0000 |
|
| ECC12 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| ECC12 | YK-4-279 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| ECC12 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| ECC12 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| ECC12 | ZM447439 | GDSC2 | 0.0100 | 10.0000 |
|
| ECC12 | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC